<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Countries with tuberculosis incidence (TB) &gt;100 per 100,000* and WHO-designated high-burden countries</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Countries with tuberculosis incidence (TB) &gt;100 per 100,000* and WHO-designated high-burden countries</h1>
<div class="graphic"><div class="figure"><div class="ttl">Countries with tuberculosis incidence (TB) &gt;100 per 100,000* and WHO-designated high-burden countries</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td>Afghanistan</td> <td>Ghana<sup>¶</sup></td> <td>Peru<sup>Δ</sup></td> </tr> <tr> <td>Angola<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Guinea-Bissau<sup>¶</sup></td> <td>Philippines<sup>Δ</sup><sup>◊</sup></td> </tr> <tr> <td>Azerbaijan<sup>Δ</sup></td> <td>Haiti</td> <td>Republic of Moldova<sup>Δ</sup></td> </tr> <tr> <td>Bangladesh<sup>Δ</sup><sup>◊</sup></td> <td>India<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Republic of the Congo</td> </tr> <tr> <td>Belarus<sup>Δ</sup></td> <td>Indonesia<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Russian Federation<sup>Δ</sup><sup>◊</sup></td> </tr> <tr> <td>Bhutan</td> <td>Kazakhstan<sup>Δ</sup></td> <td>Sao Tome and Principe</td> </tr> <tr> <td>Bolivia</td> <td>Kenya<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Senegal</td> </tr> <tr> <td>Botswana<sup>¶</sup></td> <td>Kiribati</td> <td>Sierra Leone<sup>◊</sup></td> </tr> <tr> <td>Brazil<sup>¶</sup><sup>◊</sup></td> <td>Kyrgyzstan<sup>Δ</sup></td> <td>Somalia<sup>Δ</sup></td> </tr> <tr> <td>Cambodia<sup>◊</sup></td> <td>Lao People's Democratic Republic</td> <td>South Africa<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> </tr> <tr> <td>Cameroon<sup>¶</sup></td> <td>Lesotho<sup>¶</sup><sup>◊</sup></td> <td>South Sudan</td> </tr> <tr> <td>Central African Republic<sup>¶</sup><sup>◊</sup></td> <td>Liberia<sup>¶</sup><sup>◊</sup></td> <td>Tajikstan<sup>Δ</sup></td> </tr> <tr> <td>Chad<sup>¶</sup></td> <td>Madagascar</td> <td>Thailand<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> </tr> <tr> <td>China<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Malawi<sup>¶</sup></td> <td>Timor-Leste</td> </tr> <tr> <td>Congo<sup>¶</sup><sup>◊</sup></td> <td>Marshall Islands</td> <td>Tuvalu</td> </tr> <tr> <td>Cote d'Ivoire</td> <td>Mongolia</td> <td>Uganda<sup>¶</sup></td> </tr> <tr> <td>Democratic People's Republic of Korea<sup>Δ</sup><sup>◊</sup></td> <td>Mozambique<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Ukraine<sup>Δ</sup></td> </tr> <tr> <td>Democratic Republic of the Congo<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Myanmar<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>United Republic of Tanzania<sup>¶</sup><sup>◊</sup></td> </tr> <tr> <td>Djibouti</td> <td>Namibia<sup>¶</sup><sup>◊</sup></td> <td>Uzbekistan<sup>Δ</sup></td> </tr> <tr> <td>Equatorial Guinea</td> <td>Nauru</td> <td>Vietnam<sup>Δ</sup><sup>◊</sup></td> </tr> <tr> <td>Eswatini<sup>¶</sup></td> <td>Nepal</td> <td>Zambia<sup>¶</sup><sup>◊</sup></td> </tr> <tr> <td>Ethiopia<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Nigeria<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td>Zimbabwe<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> </tr> <tr> <td>Gabon</td> <td>Pakistan<sup>Δ</sup><sup>◊</sup></td> <td> </td> </tr> <tr> <td>Gambia</td> <td>Papua New Guinea<sup>¶</sup><sup>Δ</sup><sup>◊</sup></td> <td> </td> </tr> </tbody></table></div><div class="graphic_lgnd">There is no consensus regarding the appropriate threshold for TB screening. Guidelines are developed for public health goals and therefore may not represent the best clinical choice for individual patients. Decisions regarding TB screening should be based on risk, and local or regional TB incidence data should be used to help define such risk.</div><div class="graphic_footnotes"><p>TB: tuberculosis; 
        WHO: World Health Organization; 
        TB/HIV: tuberculosis/human immunodeficiency virus; 
        MDR-TB: multidrug-resistant tuberculosis.</p>
<p>* An incidence of TB of &gt;100 per 100,000 population is associated with an annual risk of infection of approximately 1%.</p>
<p>¶ Designated as a high-burden country for TB/HIV in the WHO 2020 Global report.</p>
<p>Δ Designated as a high-burden country for MDR-TB in the WHO 2020 Global report.</p>
    
    ◊ Designated as a high-burden country for TB in the WHO 2020 Global report.</div><div class="graphic_reference">Data from:
    <ol>
<li>World Health Organization. TB burden estimates. <a href="www.who.int/teams/global-tuberculosis-programme/data" target="_blank">https://www.who.int/teams/global-tuberculosis-programme/data</a> (Accessed on June 16, 2023).</li>
<li>World Health Organization. Global tuberculosis report 2022. <a href="www.who.int/teams/global-tuberculosis-programme/tb-reports">https://www.who.int/teams/global-tuberculosis-programme/tb-reports</a> (Accessed on June 16, 2023).</li>
<li>World Health Organization. Global tuberculosis report 2020. <a href="www.who.int/publications/i/item/9789240013131h" target="_blank">https://www.who.int/publications/i/item/9789240013131h</a> (Accessed on June 16, 2023).</li>
<li>World Bank Data. <a href="data.worldbank.org/indicator/SH.TBS.INCD" target="_blank">https://data.worldbank.org/indicator/SH.TBS.INCD</a> (Accessed on June 16, 2023).</li>
</ol></div><div id="graphicVersion">Graphic 111123 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
